The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis Article

Sasaki, M, Bharwani, S, Jordan, P et al. (2003). The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis . JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 305(1), 78-85. 10.1124/jpet.102.044099

International Collaboration

cited authors

  • Sasaki, M; Bharwani, S; Jordan, P; Joh, T; Manas, K; Warren, A; Harada, H; Carter, P; Elrod, JW; Wolcott, M; Grisham, MB; Alexander, JS

sustainable development goals

authors

publication date

  • April 1, 2003

published in

keywords

  • ADHESION MOLECULE EXPRESSION
  • BOWEL-DISEASE
  • CORONARY-ARTERY DISEASE
  • CROHNS-DISEASE
  • ENDOTHELIAL-CELL-ADHESION
  • LEUKOCYTE ADHESION
  • Life Sciences & Biomedicine
  • MURINE MODEL
  • NITRIC-OXIDE SYNTHASE
  • Pharmacology & Pharmacy
  • SELECTIN EXPRESSION
  • Science & Technology
  • ULCERATIVE-COLITIS

Digital Object Identifier (DOI)

publisher

  • AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS

start page

  • 78

end page

  • 85

volume

  • 305

issue

  • 1